Experimental nasal influenza vaccine tested in kids, teens
An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at an NIAID-supported VTEU site at Saint Louis University, St. Louis, Missouri. September 18, 2018